NO910901L - Behandling av obesitas og essensiell hypertensjon og relaterte forstyrrelser. - Google Patents

Behandling av obesitas og essensiell hypertensjon og relaterte forstyrrelser.

Info

Publication number
NO910901L
NO910901L NO91910901A NO910901A NO910901L NO 910901 L NO910901 L NO 910901L NO 91910901 A NO91910901 A NO 91910901A NO 910901 A NO910901 A NO 910901A NO 910901 L NO910901 L NO 910901L
Authority
NO
Norway
Prior art keywords
treatment
obesitas
essential hypertension
related disorders
hypertension
Prior art date
Application number
NO91910901A
Other languages
English (en)
Other versions
NO910901D0 (no
Inventor
Garth J S Cooper
Brendan Leighton
Original Assignee
Amylin Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Corp filed Critical Amylin Corp
Publication of NO910901D0 publication Critical patent/NO910901D0/no
Publication of NO910901L publication Critical patent/NO910901L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/225—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

Tilførsel av antagonister og blokkere av amylin eller CGRP eller begge for behandling av sterk fedme og essensiell hypertensjon og assosierte lipidforstyrrelser og atherosklerose.
NO91910901A 1989-07-10 1991-03-07 Behandling av obesitas og essensiell hypertensjon og relaterte forstyrrelser. NO910901L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37765289A 1989-07-10 1989-07-10
PCT/US1990/003795 WO1991000737A1 (en) 1989-07-10 1990-07-10 Treatment of obesity and essential hypertension and related disorders

Publications (2)

Publication Number Publication Date
NO910901D0 NO910901D0 (no) 1991-03-07
NO910901L true NO910901L (no) 1991-04-25

Family

ID=23490003

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91910901A NO910901L (no) 1989-07-10 1991-03-07 Behandling av obesitas og essensiell hypertensjon og relaterte forstyrrelser.

Country Status (14)

Country Link
EP (1) EP0408294B1 (no)
JP (1) JPH04500688A (no)
AT (1) ATE128032T1 (no)
AU (1) AU620727B2 (no)
CA (1) CA2020786A1 (no)
DE (1) DE69022501T2 (no)
DK (1) DK0408294T3 (no)
ES (1) ES2080802T3 (no)
FI (1) FI911179A0 (no)
GR (1) GR3018442T3 (no)
IE (1) IE71195B1 (no)
NO (1) NO910901L (no)
NZ (1) NZ234428A (no)
WO (1) WO1991000737A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260275A (en) * 1990-08-14 1993-11-09 Amylin Pharmaceuticals, Inc. Hypoglycemics
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
US5264372A (en) * 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists
HU222249B1 (hu) 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
EP0503827A1 (en) * 1991-03-15 1992-09-16 Pfizer Inc. Amylin and calcitonin gene-related peptide use and antagonists thereof
WO1992020367A1 (en) * 1991-05-24 1992-11-26 Amylin Pharmaceuticals, Inc. Treatment of anorexia and related states
US5580953A (en) * 1991-08-14 1996-12-03 Amylin Pharmaceuticals, Inc. Amylin antagonist peptides and uses therefor
DK0567626T3 (da) * 1991-11-19 2001-12-17 Amylin Pharmaceuticals Inc Amylin-agonist-peptider og anvendelse deraf
WO1993019774A1 (en) * 1992-04-03 1993-10-14 Amylin Pharmaceuticals, Inc. Amylin and possibly insulin containing composition for the treatment of anorexia and related states
DE69333683T2 (de) * 1992-05-15 2005-10-27 Amylin Pharmaceuticals, Inc., San Diego Antikörper-testbesteck zur bestimmung von amylin
US5376638A (en) * 1992-09-01 1994-12-27 Amylin Pharmaceuticals, Inc. Methods for treating renin-related disorders with amylin antagonists
US5625032A (en) * 1993-07-21 1997-04-29 Amylin Pharmaceuticals, Inc. Selective amylin antagonist peptides and uses therefor
WO1996003993A2 (en) * 1994-08-05 1996-02-15 The Rockefeller University Modulation of thymocyte and t cell functional activity
US6187991B1 (en) * 1995-05-23 2001-02-13 Pfizer Inc Transgenic animal models for type II diabetes mellitus
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
CN1296384C (zh) * 1999-06-18 2007-01-24 普罗特米克斯发现有限公司 具有preptin功能的肽
DK1957106T4 (da) 2005-11-14 2019-10-28 Teva Pharmaceuticals Int Gmbh Antagonist-antistoffer, der er rettet mod calcitonin-gen-relateret peptid og fremgangsmåder til anvendelse af disse
ES2689322T3 (es) 2008-03-04 2018-11-13 Teva Pharmaceuticals International Gmbh Métodos para tratar el dolor crónico
US8623366B2 (en) 2009-08-28 2014-01-07 Labrys Biologics, Inc. Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
CN102666579A (zh) * 2009-10-30 2012-09-12 诺沃—诺迪斯克有限公司 降钙素基因相关肽的衍生物
SG11201510618YA (en) * 2013-07-03 2016-03-30 Alder Biopharmaceuticals Inc Regulation of glucose metabolism using anti-cgrp antibodies
KR20220130822A (ko) 2014-03-21 2022-09-27 테바 파마슈티컬스 인터내셔널 게엠베하 칼시토닌 유전자-관련 펩티드에 대한 길항제 항체 및 그의 사용 방법
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
EP3515937A1 (en) 2016-09-23 2019-07-31 Teva Pharmaceuticals International GmbH Treating refractory migraine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052583T3 (es) * 1986-12-04 1994-07-16 Asahi Chemical Ind Derivados de peptidos relacionados con el gel calcitonina.
GB8709871D0 (en) * 1987-04-27 1987-06-03 Turner R C Peptides
WO1989006135A1 (en) * 1988-01-11 1989-07-13 Amylin Corporation Treatment of type 2 diabetes mellitus

Also Published As

Publication number Publication date
ES2080802T3 (es) 1996-02-16
JPH04500688A (ja) 1992-02-06
WO1991000737A1 (en) 1991-01-24
DK0408294T3 (da) 1996-01-15
EP0408294A2 (en) 1991-01-16
DE69022501D1 (de) 1995-10-26
EP0408294B1 (en) 1995-09-20
AU620727B2 (en) 1992-02-20
NO910901D0 (no) 1991-03-07
IE902514A1 (en) 1991-02-13
AU5953790A (en) 1991-02-06
FI911179A0 (fi) 1991-03-08
DE69022501T2 (de) 1996-02-01
GR3018442T3 (en) 1996-03-31
CA2020786A1 (en) 1991-01-11
ATE128032T1 (de) 1995-10-15
EP0408294A3 (en) 1991-12-18
NZ234428A (en) 1997-08-22
IE71195B1 (en) 1997-02-12

Similar Documents

Publication Publication Date Title
NO910901D0 (no) Behandling av obesitas og essensiell hypertensjon og relaterte forstyrrelser.
NO885794D0 (no) Fremgangsmaate og innretning for produksjon av viskoes raaolje.
FI891767A0 (fi) Foerfarande foer framstaellning av en ljusvaogledare.
NO884363L (no) Fremgangsmaate og innretning for perforering av foringsroeri flere soner.
DE69115076D1 (de) Diarylacetylen endgekappte Polyimide.
NO903730L (no) Broennanordning.
FI901148A0 (fi) Tetrahydrokinolinderivat som aer anvaendbara vid vaord av neurodegenerativa stoerningar.
NO884426L (no) Fortoeyningsanordning og fremgangsmaate for installasjon aven dypvanns strekkstagplattform.
FR2660301B1 (fr) Dispositif pour la production d'ozone.
DE69009892D1 (de) Acetylen-bis-phthalsäure-Verbindungen und daraus hergestellte Polyimide.
DE69012298D1 (de) Heizen von Lagern und dergleichen.
EP0423075A3 (en) Mounting means for installation block for sanitary devices
NO881836D0 (no) Fremgangsmaate og anordning for installering av plastroer.
ITRM910519A0 (it) Collirio per il trattamento della ipertensione oculare
NO892257L (no) Fremgangsmaate og anordning for oppfoering av gulvkonstruksjoner.
FR2660300B1 (fr) Dispositif pour la production d'ozone.
NO885615D0 (no) Innretning for utsendelse av insektbekjempende og luktfjernende midler.
FR2655538B1 (fr) Support articule et coulissant pour paralysies du membre superieur.
IT8920065A0 (it) Procedimento per la modificazione di emulsioni di bitume mediante elastomeri.
IT8947558A0 (it) Dispositivo da tavolo per l'estrazione singola di fogli per annotazioni e simili
IT1218018B (it) Apparecchiatura per eseguire il montaggio automatico di mollette da bucato e simili
NO163155C (no) Fremgangsmaate og anordning for isetting av toppringer i lampeskjermer.
KR880022011U (ko) 전자식 냉장고의 상힌지
ITVE910061A1 (it) Dispositivo per l'azionamento automatico di portelli di macchine lavatrici, centrifugatrici e simili
IT9083415A0 (it) Dispositivo di regolazione della conicita' di confezioni tessili.